Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Plasma P-tau181 as a Marker of Progression to Alzheimer’s Disease Dementia in Subjective Cognitive Decline and Mild Cognitive Impairment.

Author:Giacomucci, Giulia   Bagnoli, Silvia   Ingannato, Assunta   Crucitti, Chiara   Padiglioni, Sonia   Moschini, Valentina   Morinelli, Carmen   Mazzeo, Salvatore   Sorbi, Sandro   Nacmias, Benedetta   Bessi, Valentina   

Session Name:P10: Aging, Dementia, and Behavioral Neurology: Dementia Diagnostics and Biomarkers  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P10.010  

Author Institution:University of Florence, Florence, Italy  AOU Careggi, Florence, Italy  Vita-Salute San Raffaele University, Milan, Italy  

Complex Neuromuscular Presentation: Acquired Rippling Muscle Disease in a Patient with Ocular Myasthenia Gravis and Pathogenic CAPN3 Mutation

Author:Zhang, Andrea   Carbunar, Olimpia   

Session Name:P10: Neuromuscular and Clinical Neurophysiology (EMG): Lessons Learned from Clinics  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P10.010  

Author Institution:University of Miami, Miami, FL  

Efficacy and Safety of Once-daily Rimegepant 75 mg Orally Disintegrating Tablet for the Short-term Preventive Treatment of Fasting-related Headache

Author:Alsaadi, Taoufik   Suliman, Reem   Yang, Jiyue   Agarwal, Ekta   Fullerton, Terence   Chou, Denise E.   Whalen, Ed   El Jadam, Caline   Al Qaisi, Ibrahim   Amin, Youssef   Alkhateri, Athra   Alsaffarini, Kareem   Abraham, Lucy   Zunaed, Zahra   Ahmed, Haytham M.   Fathy, Mohamed   Hegab,   

Session Name:P10: Headache: Advances in CGRP Inhibitors and Migraine 3  

Topic:Headache  

Program Number:P10.010  

Author Institution:American Center for Psychiatry and Neurology, Abu Dhabi, UAE, Abu Dhabi, United Arab Emirates  Pfizer Inc, New York, NY, USA, New York, NY  Pfizer Inc, Groton, CT, USA, Groton, CT  Pfizer Inc, Cambridge, MA, USA, Cambridge, MA  Pfizer Ltd, Tadworth, UK, Tadworth, United Kingdom  Pfizer Gulf FZ LLC, Dubai Media City, Dubai, UAE, Dubai Media City, Dubai, United Arab Emirates  Pfizer, Buenos Aires, Argentina, Buenos Aires, Argentina  

Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS®) Reduces Major Depressive Disorder (MDD) Symptom Severity

Author:Shawwa, Jacob   Reina, Eugenio   Ho, Alan   Roach, Caleigh   Kis, Matthew   Harvey PhD, Philip   Schulman MD, PhD, Carl   

Session Name:P10: General Neurology: New, Potential, and Innovative Treatments 2  

Topic:General Neurology  

Program Number:P10.010  

Author Institution:University of Miami Miller School of Medicine, Miami, FL  University of Miami Miller School of Medicine, Davie, FL  

Natalizumab Discontinuation in Pregnancy: Evaluating Relapse Risk in MS Patients After the Second Trimester

Author:Mohajery, Mahsa   Brewi, Shannon   Sadiq, Saud   

Session Name:P10: Multiple Sclerosis: Epidemiology and MS in Special Populations 2  

Topic:Multiple Sclerosis  

Program Number:P10.010  

Author Institution:Tisch Multiple Sclerosis Research Center of New York, New York, NY  Tisch Multiple Sclerosis Research Center of New York, New York, NJ